Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review

BACKGROUND: Omalizumab is a valuable alternative treatment for allergic bronchopulmonary aspergillosis (ABPA). The effectiveness and safety of this medication have not been confirmed. The main purpose of this study was to evaluate the effectiveness and safety of omalizumab for ABPA. METHODS: This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Cuihong, Qu, Jingjing, Zhou, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571511/
https://www.ncbi.nlm.nih.gov/pubmed/37833657
http://dx.doi.org/10.1186/s12890-023-02696-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571511/
https://www.ncbi.nlm.nih.gov/pubmed/37833657
http://dx.doi.org/10.1186/s12890-023-02696-x

Ejemplares similares